文献速递消化内镜消化道肿瘤与早癌

基于人群的队列研究:内镜后食管腺癌与肿瘤检出率及风险

Neoplasia Detection Rate and Risk of Post-endoscopy Esophageal Adenocarcinoma and Neoplasia in a Population-based Cohort Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-07-25

该研究纳入芬兰和瑞典2006至2020年间15178例新诊断巴雷特食管患者,评估内镜后食管腺癌(PEEC)和食管肿瘤(PEEN)的风险与机构肿瘤检出率(NDR)的关联。随访期间198例发生EAC,PEEC发生率为341/10万人年,调整后CDR与PEEC风险降低相关(HR 0.18)。结论提示CDR/NDR与PEEC/PEEN风险相关,但改善检出率能否降低发病率尚需进一步研究。

要点

  • PEEC占随访EAC的22.2%,发生率为341/10万人年。
  • 调整后CDR与PEEC风险降低相关(HR 0.18,95%CI 0.06-0.56)。
  • CDR与PEEN风险降低相关(HR 0.08,95%CI 0.02-0.36)。

核心结论

  • 研究提供了基于人群的CDR和NDR估计值及其与PEEC/PEEN的关联,改善CDR/NDR能否降低PEEC/PEEN发病率尚待未来研究确定。

研究设计与样本

  • 基于芬兰和瑞典2006至2020年15178例新诊断巴雷特食管患者的人群队列研究。
  • PEEC定义为BE诊断后30至365天诊断的EAC,PEEN定义为该时段诊断的HGD/EAC。
  • CDR定义为0至29天诊断的EAC,NDR定义为0至29天诊断的HGD/EAC,均以2年移动平均值计算。
  • 采用泊松模型(对数F-NDR含二次项)评估CDR/NDR与PEEC/PEEN的关联。

主要发现

  • 随访期间198例发生EAC,其中36例(18%)在内镜检查后30天内诊断,44例(22.2%)为PEEC,118例(59.6%)为 incident EAC。
  • PEEC和incident EAC的发生率分别为341/10万人年(95%CI 254-458)和193/10万人年(95%CI 161-231)。
  • 平均CDR为0.23,平均NDR为0.39。
  • 全因死亡率和EAC特异性死亡率分别为3782/10万人年(95%CI 3645-3924)和121/10万人年(95%CI 98-149)。

关键数值与推荐

  • CDR与PEEC的调整后风险比(HR)为0.18(95%CI 0.06-0.56),与PEEN的调整后HR为0.08(95%CI 0.02-0.36)。

临床怎么用

  • 内镜后食管腺癌和肿瘤风险与机构检出率相关,提高CDR/NDR可能有助于降低PEEC/PEEN风险,但因果关系需进一步验证。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Post-endoscopy esophageal adenocarcinoma (PEEC) and esophageal neoplasia (PEEN) undermine early cancer detection in Barrett's esophagus (BE). We aimed to assess the association between facility neoplasia detection rate (NDR) and risk of PEEC/PEEN among newly diagnosed patients with BE. METHODS: This population-based cohort study included 15,178 patients with BE from Finland and Sweden between 2006 and 2020. PEEC and PEEN were defined as esophageal adenocarcinoma (EAC) or HGD/EAC, respectively, diagnosed 30 to 365 days from BE diagnosis. Cancer detection rate (CDR) was defined as EAC alone and NDR as HGD/EAC diagnosed from 0 to 29 days, and both were was calculated as a 2-year moving average. Incident HGD/EAC was diagnosed >365 days from BE diagnosis. Patients were followed until HGD/EAC, death, or the end of the study period. Incidence rates and mortality rates per 100,000 person-years with 95% confidence intervals (CIs) were calculated. Associations between CDR/NDR and PEEC/PEEN were assessed using Poisson modelling with quadratic term for log(F-NDR). RESULTS: Among 198 patients who developed EAC during follow-up, 36 (18%) were diagnosed within 30 days of endoscopy, 44 (22.2%) were PEEC, and 118 (59.6%) were incident EAC. The incidence rates per 100,000 person-years for PEEC and incident EAC were 341 (95% CI, 254-458) and 193 (95% CI, 161-231), respectively. The mean CDR was 0.23, and the mean NDR was 0.39. All-cause and EAC-specific mortality rates per 100,000 person-years were 3782 (95% CI, 3645-3924) and 121 (95% CI, 98-149). The adjusted hazard ratios for PEEC and PEEN based on CDR was 0.18 (95% CI, 0.06-0.56) and 0.08 (95% CI, 0.02-0.36), respectively. CONCLUSIONS: This study has provided population-based estimates of CDR and NDR and associations between CDR/NDR and PEEC/PEEN. Future studies remain to determine whether improving CDR/NDR decrease the incidence of PEEC/PEEN.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Wani S, Santoni G, Holmberg D, et al. Neoplasia Detection Rate and Risk of Post-endoscopy Esophageal Adenocarcinoma and Neoplasia in a Population-based Cohort Study. Clin Gastroenterol Hepatol. 2025. PMID: 40716625. doi:10.1016/j.cgh.2025.07.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。